Literature DB >> 13205635

A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.

E S ORGAIN, C L RAST, H A SIEBER.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; SYMPATHOLYTICS/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13205635      PMCID： PMC2249082     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  16 in total

1.  Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease.

Authors:  R D TAYLOR; H P DUSTAN; A C CORCORAN; I H PAGE
Journal:  AMA Arch Intern Med       Date:  1952-12

2.  The control of arterial hypertension by hyphex, with an evaluation of other methods of therapy.

Authors:  H A SCHROEDER; J D MORROW
Journal:  Med Clin North Am       Date:  1953-07       Impact factor: 5.456

3.  Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.

Authors:  J H MOYER
Journal:  AMA Arch Intern Med       Date:  1953-04

4.  Orally administered hexamethonium chloride in hypertension.

Authors:  J H MOYER; S I MILLER; R V FORD
Journal:  J Am Med Assoc       Date:  1953-07-18

5.  Hexamethonium compounds in the treatment of hypertension.

Authors:  J D BLAINEY
Journal:  Lancet       Date:  1952-05-17       Impact factor: 79.321

6.  Treatment of hypertension by oral methonium compounds.

Authors:  A J CAMPBELL; J G GRAHAM; R D MAXWELL
Journal:  Br Med J       Date:  1952-02-02

7.  The effect of 1-hydrasinophthalasine in hypertension.

Authors:  N A SCHROEDER
Journal:  Circulation       Date:  1952-01       Impact factor: 29.690

8.  The treatment of hypertension with hexamethonium.

Authors:  E D FREIS; F A FINNERTY; N W SCHNAPER; R L JOHNSON
Journal:  Circulation       Date:  1952-01       Impact factor: 29.690

9.  Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium.

Authors:  R L JOHNSON; E D FREIS; H W SCHNAPER
Journal:  Circulation       Date:  1952-06       Impact factor: 29.690

10.  Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months.

Authors:  F H SMIRK; K S ALSTAD
Journal:  Br Med J       Date:  1951-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.